Subscribe to Search results

Dr Gunson stated that he doubted "whether the Newcastle and Glasgow Centres have the laboratory capability to carry out the additional work now proposed."

Published on:

The minister was informed that it was unlikely that routine screening could be introduced before 1 April 1991. In fact, the date of introduction slipped from April to July to September.

Published on:

Dr Gunson informed the Department of Health: "the other major competitor company feels disadvantaged, and has also caused problems in Scotland."

Published on:

Dr Gunson included a briefing note in case of press inquiries, which stressed the importance of selecting tests with proven reliability.

Published on:

The Central Blood Laboratories Authority Sub-Committee meeting minutes record that "Members agreed it was important for proper evaluation of the Ortho and Abbott 1&2 tests to be carried out before RTCs decided which test they would adopt." The anticipated commencement date remained 1 July 1991.

Published on:

Dr Gunson presented the preliminary report on the UKBTS study of surrogate and Chiron testing which noted: "The Chiron test had been used in first time recipients of Factor 8Y. Preliminary results had shown no positives, while most recipients of earlier concentrates were Chiron positive. Further study of stored haemophiliac sera was advocated."

Published on:

Dr Contreras and Dr Barbara warned that contacting and counselling affected donors would be "an enormous and costly undertaking", that using an assay test that took three hours would be logistically difficult, and that a confirmatory assay was still required.

Published on:

Dr Mitchell reported on the Abbott Symposium and presented US guidelines on the implementation of anti-HCV testing.

Published on:

Dr Peter Jones wrote to the Committee on Safety of Medicines setting out his argument for Armour materials to be withheld.

Published on:

Dr Rotblat delayed reporting Dr David Whitmore's HTLV-3 positive patient because Dr Whitmore had asked for confidentiality regarding the patient while he investigated the patient's lifestyle.

Published on:

In relation to the cost involved in changing form non-heat-treated to heat-treated material in the northern region, there was an argument as to whether people who were HIV antibody positive should continue to receive contaminated material.

Published on:

Dr Prince found that Generation I, Generation II and Factor 9 were not rendered virus free when they had been contaminated with HTLV-3 and heated in the dry state at 60°C for even as much as 72 hours, but in November 1985 Armour (US) refused permission to Dr Prince to make the information public.

Published on:

When he studied under Dr F C Webb and used his seminal textbook, Dr Foster had learned that albumin could be pasteurised at 60°C for 10 hours but the other fractions were heat labile.

Published on:

Dr Prince's report of further studies "Safety of Blood Derivatives Pasteurized in the Dry State" concluded that "pasteurization at 60C in the dry state had only a modest process efficacy for inactivation of HTLV-III/LAV".

Published on:

Serum hepatitis was inactivated by heating human albumin at 60°C for ten hours, but not for one hour.

Published on:

Dr Jason from CDC gave a presentation on AIDS and reported that HIV was dry heat treatment at 68°C for 24 hours inactivated HIV.

Published on:

Dr Alfred Prince conducted his further study and found that pasteurisation at 60°C in the dry state had only a modest process efficacy for inactivation of HTLV III/LAV.

Published on:

Dr Prince found that Generation I, Generation II and Factor 9 were not rendered virus free when they had been contaminated with HTLV-3 and heated in the dry state at 60 C for even as much as 72 hours, but in November 1985 Armour (US) refused permission to Dr Prince to make the information public.

Published on:

When he studied under Dr F C Webb and used his seminal textbook, Dr Foster had learned that albumin could be pasteurised at 60C for 10 hours but the other fractions were heat labile.

Published on:

Serum hepatitis was inactivated by heating human albumin at 60C for ten hours, but not for one hour.

Published on: